食品伙伴網(wǎng)訊    據(jù)歐盟食品安全局（EFSA）消息，8月7日歐盟食品安全局就噻嗪酮（buprofezin）的農(nóng)藥風(fēng)險(xiǎn)評(píng)估同行評(píng)審發(fā)布結(jié)論。評(píng)估結(jié)論建立在將噻嗪酮作為西紅柿、生菜、柑橘屬作物殺蟲(chóng)劑的基礎(chǔ)之上。在確認(rèn)數(shù)據(jù)框架下的良好農(nóng)業(yè)規(guī)范基礎(chǔ)之上，噻嗪酮用于生菜、西紅柿對(duì)消費(fèi)者構(gòu)成的風(fēng)險(xiǎn)尚未被發(fā)現(xiàn)。當(dāng)用于柑橘屬作物時(shí)，消費(fèi)者風(fēng)險(xiǎn)評(píng)估數(shù)據(jù)不充分。

    部分原文報(bào)道如下：

    Buprofezin was included in Annex I to Directive 91/414/EEC on 20 January 2011 by Commission Directive 2011/6/EU, and has been deemed to be approved under Regulation （EC） No 1107/2009, in accordance with Commission Implementing Regulation （EU） No 540/2011, as amended by Commission Implementing Regulation （EU） No 541/2011. It was a specific provision of the approval that the applicant was required to submit to the European Commission further studies regards the processing and conversion factors for consumer risk assessment by 31 January 2013.

    In accordance with the specific provision, the applicant, Nichino Europe Co, Ltd, submitted an updated dossier in January 2013, which was evaluated by the designated rapporteur Member State （RMS）， the United Kingdom, in the form of an addendum to the assessment report. In compliance with Guidance document SANCO 5634/2009 rev.4.5, the RMS distributed the Addendum to Member States, the applicant and EFSA for comments on 9 September 2014. The RMS collated all comments in the format of a reporting table, which was submitted to EFSA on 8 January 2015. EFSA added its scientific views on the specific points raised during the commenting phase in column 4 of the reporting table and finalised the Technical Report in February 2015.

    原文鏈接：http://www.efsa.europa.eu/en/efsajournal/pub/4207